BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Rating) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 61,600 shares, a drop of 16.4% from the April 30th total of 73,700 shares. Based on an average daily trading volume, of 1,140,000 shares, the short-interest ratio is currently 0.1 […]
StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a research report issued to clients and investors on Saturday. The firm set a “sell” rating on the stock. Separately, Aegis assumed coverage on BiondVax Pharmaceuticals in a research report on Wednesday, January 26th. They set a “buy” rating and a $7.00 […]
StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a report released on Friday. The firm set a “sell” rating on the stock. Separately, Aegis began coverage on shares of BiondVax Pharmaceuticals in a report on Wednesday, January 26th. They issued a “buy” rating and a $7.00 price objective on the […]
StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Get Rating) in a research note issued on Thursday. The firm set a “sell” rating on the stock. Separately, Aegis initiated coverage on BiondVax Pharmaceuticals in a report on Wednesday, January 26th. They issued a “buy” rating and a $7.00 price objective for the company. […]